Search for: "Matter of Kevin A." Results 401 - 420 of 3,775
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Apr 2011, 4:10 am
If substantial evidence supports the appointing authority’s denial of GML §207-a benefits, it must be sustained Matter of Ridge Rd. [read post]
5 Dec 2010, 7:30 am by Walter Olson
Kevin Brancato (0) Wal-Mart trampling suit (8) Wal*ocaust (1) Vaccine lawyer subpoenas Kathleen Seidel (22) [read post]
19 Aug 2020, 4:20 pm by Tom Smith
The majority of those arrests didn’t result in prosecution by District Attorney Kevin Barton, a spokesman said. [read post]
10 Nov 2010, 9:01 am by scanner1
KEVIN DeTIENNE, Individually and as Sole Operating Member of THE MONEY TRAIN, LLC, a Montana Limiited Liability Company, Defendants and Appellants, JOHN SEDMINIK, JR., Subtenant, Defendant. [read post]
21 Jun 2012, 4:00 am by Paula Black
Your authentic content matters most (developing a relationship of trust starts with your willingness to listen and share) 4. [read post]
13 Jan 2010, 1:23 pm by Kevin Jon Heller
by Kevin Jon Heller The Trial Chamber has granted certification to appeal its decision upholding the Registry's selection of Richard Harvey as stand-by counsel. [read post]
22 Mar 2007, 10:56 am
The Star's petition for access was filed after the clerk of the appellate courts, Kevin S. [read post]
28 May 2010, 5:30 pm by Kevin Jon Heller
by Kevin Jon Heller I do have a question for Ken. [read post]
7 Nov 2011, 4:59 am by Kevin Jon Heller
  The problem is that, as a matter of criminal-law theory, it is impossible to conspire to aid and abet a crime. [read post]
13 Aug 2007, 10:57 am
Kevin Drum writes: Instant analysis: It doesn't really matter. [read post]
4 Mar 2009, 5:45 am
More on Roche and Genentech's Tangled Web - by Kevin Miller, Alston & Bird As a follow-up to the excellent piece by John Jenkins, I thought the following point worth noting: Under Pure Resources, any shareholder of Genentech should be able to get Roche's tender offer enjoined until Genentech publicly discloses a summary of the financial analyses of Goldman Sachs underlying Goldman Sach's inadequacy opinion on which the Genentech special committee relied in… [read post]